These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
374 related items for PubMed ID: 12405248
1. Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients. Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M. Dig Liver Dis; 2002 Sep; 34(9):626-30. PubMed ID: 12405248 [Abstract] [Full Text] [Related]
2. Infliximab in the treatment of severe ulcerative colitis: a follow-up study. Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M. Eur Rev Med Pharmacol Sci; 2004 Sep; 8(5):235-7. PubMed ID: 15638237 [Abstract] [Full Text] [Related]
3. Infliximab for treatment of steroid-refractory ulcerative colitis. Actis GC, Bruno M, Pinna-Pintor M, Rossini FP, Rizzetto M. Dig Liver Dis; 2002 Sep; 34(9):631-4. PubMed ID: 12405249 [Abstract] [Full Text] [Related]
5. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Lawson MM, Thomas AG, Akobeng AK. Cochrane Database Syst Rev; 2006 Jul 19; (3):CD005112. PubMed ID: 16856078 [Abstract] [Full Text] [Related]
6. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids. Yamamoto-Furusho JK, Uzcanga LF. Dig Surg; 2008 Jul 19; 25(5):383-6. PubMed ID: 19005257 [Abstract] [Full Text] [Related]
7. Infliximab efficacy in pediatric ulcerative colitis. Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Inflamm Bowel Dis; 2005 Mar 19; 11(3):213-8. PubMed ID: 15735427 [Abstract] [Full Text] [Related]
8. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis]. Mocciaro F, Orlando A, Scimeca D, Cottone M. Recenti Prog Med; 2007 Nov 19; 98(11):560-4. PubMed ID: 18044405 [Abstract] [Full Text] [Related]
9. Infliximab in the treatment of steroid-dependent ulcerative colitis. Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A. Eur Rev Med Pharmacol Sci; 2004 Nov 19; 8(5):231-3. PubMed ID: 15638236 [Abstract] [Full Text] [Related]
10. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus. Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Masuda S, Inui K, Chiba T. J Gastroenterol Hepatol; 2010 May 19; 25(5):886-91. PubMed ID: 20546441 [Abstract] [Full Text] [Related]
11. Tumor necrosis factor alpha blocking agents as treatment for ulcerative colitis intolerant or refractory to conventional medical therapy: a meta-analysis. Lv R, Qiao W, Wu Z, Wang Y, Dai S, Liu Q, Zheng X. PLoS One; 2014 May 19; 9(1):e86692. PubMed ID: 24475168 [Abstract] [Full Text] [Related]
12. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C. Aliment Pharmacol Ther; 2007 Sep 01; 26(5):747-56. PubMed ID: 17697208 [Abstract] [Full Text] [Related]
13. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Jakobovits SL, Jewell DP, Travis SP. Aliment Pharmacol Ther; 2007 May 01; 25(9):1055-60. PubMed ID: 17439506 [Abstract] [Full Text] [Related]
14. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R. Dig Liver Dis; 2008 Oct 01; 40(10):821-6. PubMed ID: 18472316 [Abstract] [Full Text] [Related]
15. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK. Inflamm Bowel Dis; 2001 May 01; 7(2):83-8. PubMed ID: 11383595 [Abstract] [Full Text] [Related]
16. The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis. Bressler B, Law JK, Al Nahdi Sheraisher N, Atkinson K, Byrne MF, Chung HV, Fishman M, Partovi N, Pearson D, Penner R, Enns RA. Can J Gastroenterol; 2008 Nov 01; 22(11):937-40. PubMed ID: 19018340 [Abstract] [Full Text] [Related]
17. Infliximab is effective in acute but not chronic childhood ulcerative colitis. Russell GH, Katz AJ. J Pediatr Gastroenterol Nutr; 2004 Aug 01; 39(2):166-70. PubMed ID: 15269622 [Abstract] [Full Text] [Related]
18. A review of infliximab use in ulcerative colitis. Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB. Clin Ther; 2008 Feb 01; 30(2):223-30. PubMed ID: 18343261 [Abstract] [Full Text] [Related]
19. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Gustavsson A, Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Verbaan H, Hellström PM, Magnuson A, Halfvarson J, Tysk C. Aliment Pharmacol Ther; 2010 Oct 01; 32(8):984-9. PubMed ID: 20937043 [Abstract] [Full Text] [Related]
20. Infliximab in patients with severe steroid-refractory ulcerative colitis: Indian experience. Sood A, Midha V, Sharma S, Sood N, Bansal M, Thara A, Khanna P. Indian J Gastroenterol; 2014 Jan 01; 33(1):31-4. PubMed ID: 23999683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]